12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
週一盤前交易時段，12只醫療保健股走勢
Gainers
獲勝者
- Celldex Therapeutics (NASDAQ:CLDX) stock increased by 30.1% to $33.8 during Monday's pre-market session. The company's market cap stands at $1.5 billion. As per the press release, Q3 earnings came out 2 days ago.
- Sensei Biotherapeutics (NASDAQ:SNSE) shares moved upwards by 21.15% to $0.84. The company's market cap stands at $22.2 million.
- Baudax Bio (NASDAQ:BXRX) shares rose 14.4% to $0.25. The company's market cap stands at $2.3 million.
- CervoMed (NASDAQ:CRVO) shares moved upwards by 14.17% to $12.48. The market value of their outstanding shares is at $70.8 million.
- Repare Therapeutics (NASDAQ:RPTX) stock increased by 13.38% to $4.32. The market value of their outstanding shares is at $181.8 million.
- OptimizeRx (NASDAQ:OPRX) shares rose 11.3% to $9.45. The market value of their outstanding shares is at $170.8 million. The company's, Q3 earnings came out today.
- Celldex 療法 納斯達克股票代碼：CLDX）在週一的盤前交易中上漲30.1％，至33.8美元。該公司的市值爲15億美元。根據新聞稿，第三季度業績是在兩天前發佈的。
- 生物療法老師 納斯達克股票代碼：SNSE）股價上漲21.15％，至0.84美元。該公司的市值爲2,220萬美元。
- Baudax Bio 納斯達克股票代碼：BXRX）股價上漲14.4％，至0.25美元。該公司的市值爲230萬美元。
- cervomed 納斯達克股票代碼：CRVO）股價上漲14.17％，至12.48美元。他們流通股的市值爲7,080萬美元。
- 修復療法 納斯達克股票代碼：RPTX）股價上漲13.38％，至4.32美元。他們流通股的市值爲1.818億美元。
- OptimizerX 納斯達克股票代碼：OPRX）股價上漲11.3％，至9.45美元。他們流通股的市值爲1.708億美元。該公司今天公佈了第三季度的收益。
Losers
失敗者
- Cerus (NASDAQ:CERS) shares fell 20.8% to $1.37 during Monday's pre-market session. The market value of their outstanding shares is at $248.2 million. As per the news, the Q3 earnings report came out 2 days ago.
- MoonLake (NASDAQ:MLTX) shares declined by 18.1% to $42.0. The company's market cap stands at $2.2 billion.
- NexImmune (NASDAQ:NEXI) shares decreased by 14.68% to $2.5. The company's market cap stands at $2.6 million.
- Acurx Pharmaceuticals (NASDAQ:ACXP) shares fell 10.67% to $2.93. The company's market cap stands at $38.1 million.
- Altamira Therapeutics (NASDAQ:CYTO) shares declined by 9.47% to $0.14. The company's market cap stands at $1.0 million.
- Kazia Therapeutics (NASDAQ:KZIA) shares declined by 9.28% to $0.43. The company's market cap stands at $10.0 million. See Also:
- 塞魯斯 納斯達克股票代碼：CERS）股價在週一的盤前交易中下跌20.8％，至1.37美元。他們流通股的市值爲2.482億美元。根據消息，第三季度收益報告是在2天前發佈的。
- 月湖 納斯達克股票代碼：MLTX）股價下跌18.1％，至42.0美元。該公司的市值爲22億美元。
- nexiMune 納斯達克股票代碼：NEXI）股價下跌14.68％，至2.5美元。該公司的市值爲260萬美元。
- Acurx 製藥 納斯達克股票代碼：ACXP）股價下跌10.67％，至2.93美元。該公司的市值爲3,810萬美元。
- 阿爾塔米拉療法 納斯達克股票代碼：CYTO）股價下跌9.47％，至0.14美元。該公司的市值爲100萬美元。
- 卡齊亞療法 納斯達克股票代碼：KZIA）股價下跌9.28％，至0.43美元。該公司的市值爲1,000萬美元。 另請參閱：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。